- Home
- NRXP vs CNVS Comparison
NRXP vs CNVS Comparison
Compare NRXP & CNVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRXP | CNVS |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | United States |
| Employees | N/A | 218 |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Video Chains |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 62.2M | 65.5M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | NRXP | CNVS |
|---|---|---|
| Price | $1.86 | $2.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 1 |
| Target Price | ★ $30.67 | $9.00 |
| AVG Volume (30 Days) | ★ 520.3K | 436.5K |
| Earning Date | 01-01-0001 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 108.99 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $78,181,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $847.91 | $30.92 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 59.13 |
| 52 Week Low | $1.58 | $1.77 |
| 52 Week High | $3.84 | $7.39 |
Technical Indicators
Market Signals| Indicator | NRXP | CNVS |
|---|---|---|
| Relative Strength Index (RSI) | 44.48 | 63.60 |
| Support Level | $1.65 | $2.47 |
| Resistance Level | $2.79 | $3.49 |
| Average True Range (ATR) | 0.11 | 0.28 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 52.54 | 70.06 |
Price Performance
Historical ComparisonAbout NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About CNVS Cineverse Corp.
Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.